Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia

Haematol Blood Transfus. 1990:33:304-8. doi: 10.1007/978-3-642-74643-7_55.

Authors

R Ohno¹, S Yokomaku, M Okumara, M Tanimoto, Y Morishita, Y Morishima, Y Kodera, H Saito

Affiliation

¹ First Department of Internal Medicine, Nagoya University School of Medicine, Aichi Shokuin Hospital, Japan.

PMID: 2182424
DOI: 10.1007/978-3-642-74643-7_55

No abstract available

Publication types

Clinical Trial
Multicenter Study
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Infections / etiology
Japan / epidemiology
Leukemia, Myeloid, Acute / drug therapy*
Leukemia, Myeloid, Acute / mortality
Leukemia, Myelomonocytic, Acute / drug therapy*
Leukemia, Myelomonocytic, Acute / mortality
Middle Aged
Multicenter Studies as Topic
Neutropenia / chemically induced
Remission Induction
Survival Rate